OBJECTIVE: The main aim of the study was to evaluate the efficacy and safety profile of Nivolumab, an immune-checkpoint-inhibitor antibody, in advanced, previously treated, Non-Small Cell Lung Cancer (NSCLC) patients, in a real world setting. METHODS: We performed a retrospective, multicentre data analysis of patients who were included in the Portuguese Nivolumab Expanded Access Program (EAP). Eligibility crite...
The different quality control methods which should be used in seroimmunological assays for detection of antibodies in infectious disease are analyzed. The concepts of reliability, sensitivity, specificity, cut off, efficacy and predictive value are described, explained how they can be calculated and exemplified. The statistics which can be used for comparing results in different situations it is also referred.;...